NASDAQ:BSTC
Delisted
BioSpecifics Technologies Corp Stock News
$88.53
+0 (+0%)
At Close: May 27, 2022
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Endo International plc.
Opioid Actions in New York State Bode Ill for Mallinckrodt, Says Citi
03:48pm, Wednesday, 17'th Jun 2020
“Opioid risk is coming back,” says analyst Navann Ty, who lowered her rating on the drugmaker to Sell in the face of a lawsuit and a separate investigation by the state.
Endo International (NASDAQ:ENDP) Stock Rating Lowered by ValuEngine
02:28am, Wednesday, 17'th Jun 2020
Endo International (NASDAQ:ENDP) (TSE:ENL) was downgraded by investment analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a report released on Wednesday, ValuEngine repo
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Biospecifics Technologies (BSTC
Can These Drug Stocks Fly? It Depends on the Lawyers
11:30am, Monday, 15'th Jun 2020
Opioid and price-fixing legal woes should lead to volatile stock moves for generic-drug makers and distributors such as Teva and McKesson.
Alprazolam Market 2020-2024 | Increasing Prevalence of Anxiety Disorders to Boost Growth | Technavio
12:00am, Saturday, 13'th Jun 2020
The Global Alprazolam Market will grow by USD 90.33 mn during 2020-2024
New York Charges Drugmaker Endo with Insurance Fraud Over Opioid Claims
11:36am, Thursday, 11'th Jun 2020
New York state filed civil charges on Wednesday accusing Endo International Plc of insurance fraud for misrepresenting the safety and efficacy of its
Global Brompheniramine Market 2020 Key Players, Industry Size, Share, Segmentation, Comprehensive Analysis and Forecast by 2025
02:52am, Thursday, 11'th Jun 2020
Jun 10, 2020 (CDN Newswire via Comtex) --
Global Brompheniramine Market Growth 2020-2025 combines the essentials, definitions, categorization, and analysis...
BioSpecifics Technologies Could Surge If The FDA Approves Its 'CCH' In XiaFlex To Treat Cellulite In The Buttocks (NASDAQ:BSTC)
08:40pm, Wednesday, 03'rd Jun 2020
If approved, BSTC's collagenase clostridium histolyticum (CCH) technology could be a Blockbuster as the first ever FDA approved collagenase (or biological) ther
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q1 2020 Update
10:28am, Monday, 01'st Jun 2020
Glenview Capital Management’s 13F portfolio value decreased around two-thirds from $11.42B to $3.68B this quarter. The number of positions decreased from 50 to
The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
12:00am, Friday, 29'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 28)
ADC Therapeutics SA (NYSE:...
The isosorbide market size has the potential to grow by USD 258.77 million during 2020-2024
One Analyst Thinks BioSpecifics Technologies Corp.'s (NASDAQ:BSTC) Revenues Are Under Threat
12:30pm, Saturday, 16'th May 2020
The latest analyst coverage could presage a bad day for BioSpecifics Technologies Corp. (NASDAQ:BSTC), with the...
